FindTrial
Sign In

Comparison of oral misoprostol solution Vs misoprostol tablet for IOL

A Comparative study of outcome of induction of labor by titrated oral misoprostol solution with oral misoprostol tablet

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/12/038541
Enrollment
200
Registered
2021-12-09
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O098- Supervision of other high risk pregnancies

Interventions

Intervention1: Induction of labor: Induction of labor will be done in term female with titrated oral misoprostol solution max of 12 dose of oral solution 25 ml each to be given hourly Control Interven

Sponsors

Dr RPGMC Tanda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Singleton pregnancy with vertex presentation Gestational age between 37 and 42 weeks Bishop score Parity Intact membranes

Exclusion criteria

Exclusion criteria: All contraindications to vaginal delivery Known allergy to misoprostol Previous uterine Surgery Heart disease, renal disease and hepatic surgery Clinically suspected chorioamnionitis

Design outcomes

Primary

MeasureTime frame
Induction to onset of labor interval, induction to delivery interval Timepoint: 8 weeks—

Secondary

MeasureTime frame
Mode of delivery Neonatal outcomeTimepoint: 8 weeks—

Countries

India

Contacts

Public ContactDr Mamta mahajan

Dr.RPGMC Tanda

lovenia_8@yahoo.com9816921231

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026